Value proposition

Changing the way we see the gut

Motilent is a technology SME focused on delivering innovative services for the quantitative investigation of the gut. Motilent champions the use of novel MRI post-processing software as a cheaper and safer biomarker for Gastrointestinal and Bowel Disorders, providing quantitative end points for research, drug development and clinical decision-making.